Background & Aims Prisons are key venues for scaling-up hepatitis C virus (HCV) testing
and treatment. Complex clinical pathways and frequent movements of people in prison …

Background Timely diagnosis and treatment of hepatitis C virus (HCV) is critical to achieve
elimination goals. This study evaluated the cost-effectiveness of point-of-care testing …

Following the availability of highly effective direct-acting antivirals (DAAs) to treat hepatitis C
infection, the uptake of treatment by people living with hepatitis C rose dramatically in high …

Background Prison-based hepatitis C treatment is safe and effective; however, many
individuals are released untreated due to time or resource constraints. On community re …

Australia has committed to WHO goals to eliminate hepatitis C virus (HCV) as a public health
threat by 2030. 1 People in prison remain a priority for hepatitis C elimination due to high …

Case detection remains a major challenge for hepatitis C virus (HCV) elimination. We have
previously published results from a pilot of an emergency department (ED) semiautomated …

Financial incentives may reduce opportunity costs associated with people who become lost
to follow‐up in hepatitis C treatment programs. We estimated the impact that different …

Following the availability of highly effective direct-acting antivirals (DAAs) to treat hepatitis C
infection, the uptake of treatment by people living with hepatitis C rose dramatically in high …

Background Co-located hepatitis C treatment at syringe service programs (SSP) is an
emerging model of care for people who inject drugs (PWID). Implementation of these models …

Objective Curative treatments for hepatitis C virus (HCV) infection are available, but access
and barriers to treatment can delay initiation. We investigated the time to first negative RNA …